Fat Cells May Fight Breast Cancer, Until Obesity Shuts Them Down

Fat has long been treated as a passive bystander in cancer, something that just sits there and maybe helps tumors grow when there’s too much of it. New research flips that idea completely. Fat cells from lean mice actively pump out a molecule called 9S-HODE that kills breast cancer cells, and human breast tissue from leaner people carries more of it too. That protective signal drops sharply with obesity, potentially opening the door for tumors to grow unchecked.

9S-HODE comes from fat cells that surround breast tissue. In lean mice, these fat cells produce high levels of the compound, triggering a form of cell death called ferroptosis that causes cancer cells to self-destruct through a chain reaction involving iron and damaged fat molecules inside the cell. In obese mice, levels of the molecule were much lower and tumors grew faster. Human breast tissue from leaner donors also contained more of the molecule than tissue from obese donors.

Published in the journal Science, the study, led by researchers at the University of Utah, offers a compelling biological explanation for how obesity can promote breast tumor growth. Rather than obesity simply adding something harmful, the research suggests it strips away a natural defense that lean bodies rely on to keep tumors in check.

How Obesity Shuts Down Breast Cancer’s Natural Defense

Researchers started with a simple comparison. They put mice on either a high-fat diet or a standard diet for several weeks, then injected breast cancer cells into their mammary tissue. Tumors grew noticeably faster in the obese mice than in the lean mice. That pattern held across several types of breast cancer cells, including both mouse and human cancer cells implanted into mice, covering multiple forms of the disease.

To figure out why, the scientists isolated fat cells from lean and obese mice and collected the fluid these cells released. They applied that fluid to cancer cells growing in lab dishes. Fluid from lean fat cells slowed cancer growth dramatically. Fluid from obese fat cells did nothing. That pointed researchers toward something released by the fat cells themselves, and showed lean fat cells were doing something obese ones were not.

Looking closer at the cancer cells, the team found signs of ferroptosis, including damage to fat molecules in cell membranes and a buildup of iron inside the cells. Blocking ferroptosis with drugs restored cancer cell growth even when lean fat cell fluid was present, confirming this mechanism. Drugs that block other forms of cell death had no effect, pointing specifically at ferroptosis as the cause.

From there, researchers went hunting for the exact molecule responsible. Using chemical filtering steps and a lab technique that identifies molecules by weight, they narrowed the list down and zeroed in on 9S-HODE. Adding this molecule alone to cancer cells was enough to trigger the same cell death seen with the full lean fat cell fluid. A closely related molecule, 13S-HODE, was far less potent, underscoring how specific this signal is.

Researchers also tested whether the effect held up in living animals, beyond lab dishes. Mice with tumors received daily injections of a drug that blocks ferroptosis. In lean mice, blocking ferroptosis made tumors grow faster, showing that this cell-death process was actively holding tumors back. In obese mice, the same drug made no difference, since ferroptosis was already suppressed. When researchers went the opposite direction and injected 9S-HODE directly into tumors in obese mice, tumor growth slowed noticeably across several cancer types.

Perhaps most telling for humans, the researchers examined breast tissue donated by people who had undergone breast reduction surgery or enrolled in a tissue donation program after death. People with a body mass index above 30 had significantly lower levels of the molecule in their breast tissue than people with a body mass index below 25. The higher a person’s BMI, the lower their levels of the protective molecule tended to be. When the molecule was tested on tumor samples grown directly from breast cancer patients, it slowed their growth too, suggesting the effect is not confined to mice.

Why Breast Cancer Cells Are Vulnerable, but Healthy Cells Are Not

One puzzle the researchers solved is why this molecule targets cancer cells without harming healthy breast tissue. Normal cells exposed to the same lean fat cell fluid did not die. Instead, they briefly paused their growth and built up small pockets of stored fat inside themselves, which appeared to buffer them against the damage that triggers ferroptosis. When researchers blocked healthy cells from forming these fat pockets, the cells became vulnerable to the same cancer-killing effect. Cancer cells, by contrast, do not build these protective pockets efficiently, leaving them exposed. That difference could matter if researchers eventually develop the molecule into a treatment, though experiments so far in cells and animals do not establish whether it would be safe in people.

Mouse experiments involved small groups, typically five to nineteen animals per group depending on the tumor type, with human tissue comparisons and patient tumor samples adding support across a smaller set of individuals.

What This Means for Breast Cancer and Obesity

Obesity has long been flagged as a risk factor for breast cancer, but this research reframes the story. It’s not simply that excess fat adds something dangerous. In this case, lean fat tissue actively suppressed tumor growth, and that protection eroded with obesity in mice. Human breast tissue showed a matching pattern, with higher BMI linked to lower levels of the molecule. Restoring the missing molecule points toward a promising drug target rather than a simple warning about body weight. The findings don’t suggest people can eat or exercise their way to higher levels of this molecule, but they do offer a new lead for a disease that remains hard to treat once it turns aggressive.

Disclaimer: This article summarizes peer-reviewed research for a general audience and is for informational purposes only. It is not medical advice. The study was conducted primarily in mice and laboratory models, with supporting measurements in human tissue; its findings have not been tested as a treatment in people. Anyone with questions about breast cancer risk, obesity, or their own health should consult a qualified healthcare professional.